{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PLACEBO&page=84", "query": { "intervention": "PLACEBO", "page": 84 }, "page_size": 10 }, "pagination": { "page": 84, "page_size": 10, "total_count": 33137, "total_pages": 3314, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PLACEBO&page=85&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PLACEBO&page=83&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T08:38:09.011Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01156792", "title": "Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FP 100", "type": "DRUG" }, { "name": "GSK2190915 100", "type": "DRUG" }, { "name": "GSK2190915 300", "type": "DRUG" }, { "name": "montelukast", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "FP/SAL 100/50", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "FEMALE", "summary": "12 Years and older · Female only" }, "enrollment_count": 162, "start_date": "2010-09", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2017-04-05", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Huntington Beach, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01156792" }, { "nct_id": "NCT05478707", "title": "Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 1", "Endothelial Dysfunction" ], "interventions": [ { "name": "Dulaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AdventHealth Translational Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 47, "start_date": "2023-10-05", "completion_date": "2028-07-30", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05478707" }, { "nct_id": "NCT02338336", "title": "A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Plantar Warts" ], "interventions": [ { "name": "Nowarta110", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nowarta Biopharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2015-02", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2016-11-04", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 1, "location_summary": "Huntington Beach, California", "locations": [ { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02338336" }, { "nct_id": "NCT00549211", "title": "A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obstetric Labour, Premature", "Premature Ejaculation" ], "interventions": [ { "name": "GSK557296", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "18 Years to 45 Years · Male only" }, "enrollment_count": 42, "start_date": "2007-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-03-19", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00549211" }, { "nct_id": "NCT03332771", "title": "Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Sotagliflozin (SAR439954)", "type": "DRUG" }, { "name": "Glimepiride", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lexicon Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 954, "start_date": "2017-12-01", "completion_date": "2019-09-06", "has_results": true, "last_update_posted_date": "2021-05-11", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 115, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Anaheim, California + 101 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Canoga Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03332771" }, { "nct_id": "NCT06031844", "title": "A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Heart Disease" ], "interventions": [ { "name": "DFV890", "type": "DRUG" }, { "name": "DFV890 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 24, "start_date": "2023-10-16", "completion_date": "2024-12-23", "has_results": true, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 6, "location_summary": "Northridge, California • Boca Raton, Florida • Jacksonville, Florida + 3 more", "locations": [ { "city": "Northridge", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Greensboro", "state": "North Carolina" }, { "city": "Rapid City", "state": "South Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06031844" }, { "nct_id": "NCT07090044", "title": "Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Vein Occlusion", "Macular Degeneration Choroidal Neovascularization", "Macular Edema", "Diabetic Retinopathy" ], "interventions": [ { "name": "Bromfenac Sodium 0.07%", "type": "DRUG" }, { "name": "Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly", "type": "DRUG" }, { "name": "Propylene Glycol Preservative-free Artificial Tears", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Retina Research Institute, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2021-08-20", "completion_date": "2022-12-08", "has_results": false, "last_update_posted_date": "2025-07-29", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07090044" }, { "nct_id": "NCT00290134", "title": "A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypogonadism" ], "interventions": [ { "name": "Fispemifene once daily for 4 weeks", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "QuatRx Pharmaceuticals Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "MALE", "summary": "40 Years and older · Male only" }, "enrollment_count": 100, "start_date": "2006-02", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2008-03-03", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 16, "location_summary": "Huntsville, Alabama • Modesto, California • Aurora, Colorado + 13 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Modesto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "New Port Richey", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00290134" }, { "nct_id": "NCT01521598", "title": "A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Painful Diabetic Neuropathy" ], "interventions": [ { "name": "SKL11197", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SK Life Science, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 128, "start_date": "2012-01", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2015-06-11", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 13, "location_summary": "Northport, Alabama • Hot Springs, Arkansas • Little Rock, Arkansas + 10 more", "locations": [ { "city": "Northport", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01521598" }, { "nct_id": "NCT00382798", "title": "Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Healthy Volunteers", "Hepatitis C Virus" ], "interventions": [ { "name": "RO5024048", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pharmasset", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 75, "start_date": "2006-10", "completion_date": "2008-09", "has_results": false, "last_update_posted_date": "2009-04-27", "last_synced_at": "2026-11-04T08:38:09.011Z", "location_count": 7, "location_summary": "San Francisco, California • Aurora, Colorado • Gainesville, Florida + 4 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT00382798" } ] }